These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 37427544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
    Tripathi D, B H MP, Sahoo J, Kumari J.
    Recent Adv Drug Deliv Formul; 2024; 18(2):79-99. PubMed ID: 38062659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A.
    Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284
    [Abstract] [Full Text] [Related]

  • 6. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
    Fridgeirsdottir GA, Harris RJ, Dryden IL, Fischer PM, Roberts CJ.
    Mol Pharm; 2018 May 07; 15(5):1826-1841. PubMed ID: 29533634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kollidon® VA 64 and Soluplus® as modern polymeric carriers for amorphous solid dispersions.
    Strojewski D, Krupa A.
    Polim Med; 2022 May 07; 52(1):19-29. PubMed ID: 35766434
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E, Smeets A, Vergaelen M, De la Rosa VR, Hoogenboom R, Van den Mooter G.
    Eur J Pharm Biopharm; 2019 Nov 07; 144():79-90. PubMed ID: 31499162
    [Abstract] [Full Text] [Related]

  • 10. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
    Tran PHL, Lee BJ, Tran TTD.
    Eur J Pharm Biopharm; 2021 Jul 07; 164():13-19. PubMed ID: 33887388
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
    Alzahrani A, Nyavanandi D, Mandati P, Youssef AAA, Narala S, Bandari S, Repka M.
    Int J Pharm; 2022 Aug 25; 624():121951. PubMed ID: 35753536
    [Abstract] [Full Text] [Related]

  • 13. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A, Li L, Marsac P, Marks B, Liu Z, Brown C.
    Int J Pharm; 2016 May 30; 505(1-2):107-14. PubMed ID: 27012984
    [Abstract] [Full Text] [Related]

  • 14. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
    Tan DK, Davis DA, Miller DA, Williams RO, Nokhodchi A.
    AAPS PharmSciTech; 2020 Nov 08; 21(8):312. PubMed ID: 33161479
    [Abstract] [Full Text] [Related]

  • 15. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA, Lehmkemper K, Sobich E, Hughes TF, Giesen DJ, Zhang T, Krauter CM, Winget P, Degenhardt M, Kyeremateng SO, Browning AR, Shelley JC.
    Mol Pharm; 2021 Nov 01; 18(11):3999-4014. PubMed ID: 34570503
    [Abstract] [Full Text] [Related]

  • 16. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF, Pereira A, Cardoso S, Cadonau S, Werner K, Pinto RMA, Simões S.
    Mol Pharm; 2020 Feb 03; 17(2):554-568. PubMed ID: 31774685
    [Abstract] [Full Text] [Related]

  • 17. Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.
    Kallakunta VR, Sarabu S, Dudhipala N, Janga KY, Bandari S, Zhang F, Repka MA.
    Eur J Pharm Biopharm; 2021 Nov 03; 168():184-194. PubMed ID: 34464695
    [Abstract] [Full Text] [Related]

  • 18. Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.
    Nambiar AG, Singh M, Mali AR, Serrano DR, Kumar R, Healy AM, Agrawal AK, Kumar D.
    AAPS PharmSciTech; 2022 Sep 02; 23(7):249. PubMed ID: 36056225
    [Abstract] [Full Text] [Related]

  • 19. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y, Caron V, Jones DS, Healy AM, Andrews GP.
    J Pharm Pharmacol; 2014 Feb 02; 66(2):256-74. PubMed ID: 24192445
    [Abstract] [Full Text] [Related]

  • 20. Thermal Stability of Amorphous Solid Dispersions.
    Jelić D.
    Molecules; 2021 Jan 05; 26(1):. PubMed ID: 33466393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.